Please select the service you would like to book:


MSI Reproductive Choices UK comment on the reclassification of the progestogen-only pill

Press releases  •  9 July 2021  •  2 min read



Media statement

London, 9th July 2021

If you are covering the reclassification of the progestogen-only pill, you may find the following statement from MSI Reproductive Choices UK helpful.

Simphiwe Sesane contraceptive nurse and faculty registered trainer at MSI Reproductive Choices said:

“The reclassification of the progestogen-only pill, which can now be sold directly by a pharmacist without a prescription, is a great step forward. It will improve access and provide anyone seeking an extremely safe method of contraception more choice over how and where they access it. All too often our teams speak to people who have become pregnant while on contraception waiting lists and these challenges have only been exacerbated by the global pandemic, so this initiative is especially welcome in that context.

“However, while this reclassification is a positive move, cost will be a barrier for some. Progestogen-only contraception will continue to be available at no cost from GPs and sexual and reproductive health services, but ultimately we would like to see it available for free through NHS community pharmacies too.”

For further information please contact:


Telephone: +44 (0) 7769 166 516



Related posts


28 November 2023  •  4 min read

Joint release on amendment to the Criminal Justice Bill

It can never be in the public interest for anyone to face prosecution for ending their own pregnancy.


18 October 2023  •  5 min read

One year on from milestone Commons vote, safe access zones are still not in place

A year ago today, MPs voted to introduce safe access zones around abortion clinics – but they are still not implemented.


12 October 2023  •  6 min read

Nearly 90% of Britons support abortion in the UK

A new YouGov UK poll today demonstrates once again that Britain is an overwhelmingly pro-choice nation.